Item 1.01. Entry into a Material Definitive Agreement

As previously disclosed, on March 30, 2021, Integrated Ventures, Inc. (the "Company") entered into securities purchase agreements (the "Purchase Agreements") with two institutional investors (the "Purchasers"), for the offering (the "Offering") of (i) 30,000,000 shares of common stock ("Shares"), par value $0.001 per share, of the Company ("Common Stock") and (ii) common stock purchase warrants ("Warrants") to purchase up to an aggregate of 30,000,000 shares of Common Stock, which are exercisable for a period of five years after issuance at an initial exercise price of $0.30 per share, subject to certain adjustments, as provided in the Warrants, with each of the Purchasers receiving Warrants in the amount equal to 100% of the number of Shares purchased by such Purchaser and each Share and accompanying Warrant offered at a combined offering price of $0.30.

On September 13, 2022, the Company and one of the Purchasers entered into a letter agreement (the "September 13 Amendment Agreement") whereby the Company agreed to amend the terms of such Purchaser's Warrants to purchase up to 15 million shares to provide effective as of June 29, 2022 reduce the exercise price thereof to $0.001, subject to adjustment therein, and waive the "exploding feature" of the Anti-Dilution Provision in the Warrant that would otherwise have effected an increase in the number of warrant shares as a result of an exercise price reduction so as to result in the same aggregate value of the warrant shares multiplied by the exercise price. Additionally, other than an Exempt Issuance, as defined in the Warrants, from the date hereof until 90 days after the date hereof, neither the Company nor any subsidiary of the Company may issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents (as defined in the Warrants).

On September 15, 2022, the Company and the other Purchaser entered into a letter agreement (the "September 15 Amendment Agreement") whereby the Company agreed to amend the terms of s such Purchaser's Warrants to purchase up to 15 million shares to provide, effective as of August 30, 2022 reduce the exercise price thereof to $0.001, subject to adjustment therein, and waive the "exploding feature" of the Anti-Dilution Provision in the Warrant that would otherwise have effected an increase in the number of warrant shares as a result of an exercise price reduction so as to result in the same aggregate value of the warrant shares multiplied by the exercise price. Additionally, other than an Exempt Issuance, as defined in the Warrants, from the date hereof until 90 days after the date hereof, neither the Company nor any subsidiary of the Company may issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents (as defined in the Warrants).

Item 1.01 of this Current Report on Form 8-K contains only a brief description of the material terms of the Warrants, the September 13 Amendment Agreement, and the September 15 Amendment Agreement, and does not purport to be a complete description of the rights and obligations of the parties thereunder, and such descriptions are qualified in their entirety by reference to the full text of the Warrants and the Amendment Agreements, the forms of which are attached as Exhibits 4.1, 4.2 and 4.3, respectively, to this Current Report on Form 8-K, and are incorporated herein by reference.






2

Item 9.01. Financial Statements and Exhibits





(d) Exhibits



Exhibit     Description
No.

  Exhibit     Form of Warrant (incorporated by reference to Exhibit 4.1 of the
4.1         Company's Current Report on Form 8-K filed on April 2, 2021)
  Exhibit     Form of September 13 Amendment Agreement
4.2
  Exhibit     Form of September 15 Amendment Agreement
4.3
Exhibit     Cover Page Interactive Data File (embedded within the Inline XBRL
104         Document).





3

© Edgar Online, source Glimpses